This result is in line with other observations in the literature indicating that the disruption of the mouse PRL3 gene reduced colon tumor formation in carcinogen-treated mice [23], and that PRL3 expression was associated with tumor initiation and self-renewal in colorectal carcinoma [24]. The gene discussed is PTP4A3; the disease is colonic neoplasm.